KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Csx (CSX) Long-Term Investments (2016 - 2025)

Csx (CSX) has disclosed Long-Term Investments for 15 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 4.52% to $2.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 billion, a 4.52% increase, with the full-year FY2025 number at $2.6 billion, up 4.52% from a year prior.
  • Long-Term Investments was $2.6 billion for Q4 2025 at Csx, up from $2.6 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.6 billion in Q4 2025 to a low of $2.0 billion in Q1 2021.
  • A 5-year average of $2.3 billion and a median of $2.4 billion in 2023 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 103.46% in 2021, then grew 3.28% in 2023.
  • Csx's Long-Term Investments stood at $2.1 billion in 2021, then grew by 9.19% to $2.3 billion in 2022, then rose by 4.58% to $2.4 billion in 2023, then grew by 5.13% to $2.5 billion in 2024, then rose by 4.52% to $2.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CSX's Long-Term Investments are $2.6 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.6 billion (Q2 2025).